Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UroLift vs Tamsulosin for BPH
NCT04987892Phase 4Recruiting
- Sponsor
- NeoTract
- Start
- Dec 2021
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by NeoTract. Primary endpoint: International Prostate Symptom Score at 3 months. Started Dec 2021; status: recruiting.
Beyond the preview
Go deeper on NCT04987892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04987892.